The Influence of Fibrinogen and Fibrin on Thrombin Generation - Evidence for Feedback Activation of the Clotting System by Clot Bound Thrombin

Summary

In plasma the bulk of thrombin generation takes place after a clot has formed. We therefore investigated in what way the clot influences thrombin generation in plasma. The forming clot withdraws thrombin from free solution. Consequently less thrombin activity is found and less thrombin-inhibitor complexes are formed. The thrombin that is adsorbed to the clot reduces the lag time before thrombin generation in intrinsically or extrinsically triggered platelet poor plasma as well as in platelet rich plasma. We investigated the mechanism of this activation.

Clots were obtained by recalcification of plasma or by the addition of thrombin-like enzymes (Reptilase, Agihal) from snake venoms. They were thoroughly washed until the washing fluid was devoid of any detectable clotting enzyme activity. In platelet poor plasma (PPP), thrombin-induced clots shorten the factor Va-dependent lag-time of thrombin generation in the extrinsic system as well as the factor VUIa-dependent thrombin generation in the intrinsic system. Factor V or factor VII preparations that in itself hardly influence thrombin generation patterns aquire the capacity to shorten these lag-times when incubated with clot. The last washing fluid of the clot is inactive. Snake venom induced clots are not active either. Clots that are incubated in heparinised plasma for 1 h or more are as active as clots from normal plasma are. A role of factor Xa can not be excluded but must be minor because a clot made by addition of thrombin to plasma from which the factors II, VII, IX and X have been removed is as active as a clot from normal plasma is.

When added to recalcified platelet rich plasma (PRP), in which the lag-time of thrombin formation is dependent upon activation of platelet procoagulant phospholipid activity, any type of clot shortens the lagtime before the burst of thrombin generation. Clots that are obtained by snake venom enzymes are also active in this system. This indicates that fibrin alone is capable to induce the procoagulant phospholipid activity in platelets.

We conclude that three known thrombin-dependent feedback activations in the clotting system (factor V, factor VIII and platelets) are efficiently supported by thrombin bound to the fibrin clot and that there is an additional activating effect of fibrin on the procoagulant action of platelets.

• References

• 1 Blombäck B, Hessel B, Hogg D, Therkildsen L. A two step fibrinogen fibrin transition in blood coagulation. Nature 1978; 275: 501-505
• 2 Liu CY, Nossel HL, Kaplan KL. The binding of thrombin by fibrin. J Biol Chem 1979; 254: 10421-10425
• 3 Kaminski M, McDonagh J. Inhibited thrombins, interactions with fibrinogen and fibrin. Biochem J 1987; 242: 881-887
• 4 Wilner GD, Danitz MP, Mudd S, Hsieh K, Fenton JW. Selective immobilization of a-thrombin by surface bound fibrin. J Lab Clin Med 1981; 97: 403-411
• 5 Hogg PJ, Jackson CM. Fibrin monomer protects thrombin from inactivation by heparin antithrombin III: Implications for heparin efficacy. Proc Natl AcadSci USA 1989; 86: 3619-3623
• 6 Liu YC, Kaplan LK, Makowitz HA, Nossel LH. Thermodynamic characterization of thrombin binding by cross linked and non cross linked fibrin in the presence and absence of Ca2+. The Journal of Biol Chem 1980; 255: 7627-7630
• 24 Seegers WH. Prothrombin Harvard University Press; Massachusetts: 1962: 286
• 8 Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsh J. Clot bound thrombin is protected from inhibition by heparin antithrombin III but is susceptible to inactivation by antithrombin III independent inhibitors. J Clin Invest 1990; 86: 385-391
• 9 Francis WC, Markham ER, Barlow HG, Florack MT, Dobrzynski MD, Marder JV. Thrombin activity of fibrin thrombi and soluble plasmic derivatives. J Lab Clin Med 1998; 102: 220-230
• 10 Prins MH, Weitz JI. Heparin inhibits the amplification of coagulation mediated by clot-bound thrombin. Thromb Haemost 1991; 65: 759 abstract 319
• 11 Bendayan P, Boccalon H, Dupouy D, Boneu B. Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins. Thromb Haemost 1994; 71: 576-580
• 12 Bendayan P, Boneu B, Boccalon H. Dermatan sulfate is a more potent inhibitor of clot bound thrombin than unfractionated and low molecular weight heparins. Poster presentation XlVth Congress of the International Society on Thromb Haemost New York; USA: 1993
• 13 Buchanan A. Original communications on the coagulation of the blood and other fibriniferous liquids. London Med Gaz 1845
• 14 Hemker HC. Feedback mechanisms in blood coagulation and their inhibition by heparins. In: FEBS symposium. Hemker CH. ed Haemostasis; 1991: 21
• 15 Hurlet Birk Jensen A, Béguin S, Josso F. Factor V and VIII activation (in vivo) during bleeding. Evidence of thrombin formation at the early stage of haemostasis. Path Biol 1976; 24: 6-10
• 16 Newcomb TF, Hoshida M. Factor V and thrombin. Scad J Clin Lab Invest 1965; 17 (Suppl. 84) 61-69
• 17 Biggs R, MacFarlane RG, Denson KWE, Ash BJ. Thrombin and the interactions of factors VIII and IX. Brit J Haemat 1965; 11: 276-295
• 18 Suzuki K, Dahlbäck B, Stenflo J. Thrombin catalyzed activation of human coagulation factor V. J Biol Chem 1982; 257: 6556-6564
• 19 Pieters J, Lindhout T, Hemker HC. In situ generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin activated plasma. Blood 1989; 74: 1021-1024
• 20 Rapaport SI, Hjort PF, Patch MJ. Further evidence that thrombin activation of factor VIII is an essential step in intrinsic clotting. Scand J Clin Lab Invest 1965; 17 (Suppl. 01) 84-88
• 21 Davey MG, Luscher EF. Action of thrombin and other proteolytic enzymes on blood platelets. Nature 1967; 216: 857-858
• 22 Bevers EM, Comfurius P, Van Rijn JLML, Hemker HC, Zwaal RFA. Generation of Prothrombin converting activity and the exposure of phos-phatidylserine at the outer surface of platelets. Eur J Biochem 1982; 122: 429-436
• 23 Rosing J, Tans G, Govers-Riemslag JWP, Zwaal RFA, Hemker HC. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255 (01) 274-283
• 24 Van Dieijen G, Tans G, Rosing J, Hemker HC. The role of phospholipid and factor Villa in the activation of bovine factor X. J Biol Chem 1981; 256: 3433-3442
• 25 Baruch D, Hemker HC, Lindhout T. Kinetics of thrombin-induced release and activation of platelet factor V. Eur J Biochem 1986; 154: 213-218
• 26 Willems GM, Lindhout T, Hermens WT, Hemker HC. Simulation model for thrombin generation in plasma. Haemostasis 1991; 21: 197-207
• 27 Béguin S, Kessels H, Hemker HC. Feedback reactions in blood coagulation are mediated by fibrin bound thrombin which is not inhibited by heparin (abstract). Thromb Haemost 1993; 69: 811
• 28 Hemker HC, Willems GM, Béguin S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 1986; 56: 9-17
• 29 Hemker HC, Wielders S, Béguin S. The thrombin potential, a parameter to assess the effect of antithrombotic drugs on thrombin generation. In: Fraxiparine. Bounameaux H, Samama M, ten Cate JW. eds Stuttgart: Schattauer; New York: 1990: 89-101
• 30 Béguin S, Lindhout T, Hemker HC. The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin. Thromb and Haemost 1989; 61 (01) 25-29
• 31 Hendrix H, Lindhout T, Mertens K, Engels W, Hemker HC. Activation of human prothrombin by stoichiometric levels of staphylocoagulase. J Biol Chem 1983; 258: 3637-3644
• 32 Béguin S, Dol F, Hemker HC. Factor IXa inhibition contributes to heparin effect. Thromb and Haemost 1991; 66 (03) 306-309
• 33 Kessels H, Béguin S, Hemker HC. The role of thrombin feedback reactions and factor Xa in clotting human plasma (abstract). Thromb Hemost 1993; 69: 810
• 34 Hemker HC, Béguin S. The mode of action of heparins in vitro and in vivo. Heparin and Related Polysaccharides. Plenum Press; New York: 1992
• 35 Lindhout T, Blezer R, Hemker HC. The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasma. Thromb Haemost 1990; 64 (03) 464-468
• 36 Eisenberg PR, Siegel JE, Abendschein DR, Miletich JP. Importance of factor Xa in determining the procoagulant activity of whole-blood clots. J Clin Invest 1993; 91: 1877-1883
• 37 Hemker HC. The mode of action of heparin in plasma. In: Xlth Congress Thrombosis Haemostasis, Brussels. Verstraete M, Vermylen J, Lijnen HR, Amout J. eds Leuven University Press; Leuven: 1987: 17-36
• 38 Beguin S, Lindhout T, Hemker HC. The mode of action of heparin in plasma. Thromb Haemost 1988; 60: 457-462
• 39 Foster WB, Nesheim ME, Mann KG. The factor Xa catalyzed activation of factor V. J Biol Chem 1983; 254: 13970
• 40 Monkovic DB, Tracy PB. Activation of human factor V by factor Xa and thrombin. Biochemistry 1990; 29: 1118-1128
• 41 Vehar GA, Davie EW. Preparation and properties of bovine factor VIII (Antihemophilic factor). Biochemistry 1980; 19 (003) 401-410
• 42 Lollar P, Knutson GJ, Fass DN. Activation of porcine factor VIII by thrombin and factor Xa. Biochemistry 1985; 24: 8056-8064
• 43 Schoen P, Lindhout T. The in situ inhibition of prothrombinase-formed human α-thrombin and meizothrombin (des fragment 1) by antithrombin III and heparin. J Biol Chem 1987; 262: 11268-11274
• 44 Sandberg H, Andersson LO, Hoglund S. Isolation and characterisation of lipid-protein particles containing platelet factor 3 released from human platelets. Biochem J 1982; 203: 303-311
• 45 Simms P, Wiedmer T, Esmon CT, Weiss HJ, Shatil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. J Biol Chem 1989; 264: 17049-17053